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Atrophic rhinitis (AR) is a significant disease and management problem to swine producers worldwide. 1, 9 For some time, Bordetella bronchiseptica was considered to be the primary etiologic agent of AR. 7, 10 However, current evidence
indicates that toxigenic strains of Pasteurella multocida type D may also play a role in this disease process. 1, 9 Pasteurella multocida type D is a fastidious microorganism, and often, when taken from turbinates, it will not initially grow on standard blood agar (trypticase soy with 5% defibrinated sheep blood), a thus requiring mouse inoculation to recover the isolate. Because Bordetella bronchiseptica is readily recovered from swine with AR and P. multocida is not, the role of P. multocida has not been fully appreciated. 2 Briefly, the medium was prepared with Columbia blood agar base supplemented with 5% defibrinated sheep blood, and it contained a final concentration of 2 µg/ml neomycin and 3.5 µg/ ml of bacitracin.
a,c,d The plates were streaked for isolation and incubated aerobically at 35 C for 24-48 hours. Bacterial growth was identified by standard methods. Several colonies of P. multocida were picked to trypticase soy broth a and incubated at 35 C to achieve a nephelometer reading (API standardized reader) f of 0.5 (McFarland scale). A 10-µ1 inoculum was then transferred to 10 ml of Ca++ Mg++ supplemented MH broth and mixed.
e An automated device was used to inoculate the microdilution tray, which was then covered with an adhesive plastic and incubated at 35 C for 18-24 hours. The minimum inhibitory concentration (MIC) results were read using a reader e coupled to a computer. g The MIC of the antimicrobial agents was interpreted and reported as previously described. 5, 6 Ranges of susceptibility were noted along with the MIC that inhibited 50% (MIC,,) and 90% (MIC, Table 1 . Most isolates were susceptible to low concentrations (MIC,,) of ampicillin (0.25 µg/ml), trimethoprim/sulfa (0.25 µg/ml), cephalothin (0.5 &ml), and penicillin (0.25 &ml). Marked resistance was found with spectinomycin (32 &ml), sulfadimethoxine (>400 µg/ml), and tylosin (25 &ml). The MIC,, of erythromycin and kanamycin was 4 µg/ml and that of gentamicin was 2 µg/ml. The MIC,, of sulfachlorpyridazine was 100 µg/ml. The MIC,, of oxytetracycline was 1 µg/ ml and the MIC,, was 16 µg/ml
The E. coli ATCC 25922 produced acceptable MIC values for which data are available. e Repetitive tests demonstrated MIC values for the following antimicrobial agents µg/ml) tylosin >40, sulfadimethoxine 50, sulfachlorpyridazine 25, and spectinomycin 12.
The MIC determinations of the P. multocida type D isolates are important. Although susceptibility was based on standard criteria such as achievable serum levels, marked susceptibility was found with ampicillin, trimethoprim/sulfa, cephalothin, and penicillin. The MIC of sulfachlorpyridazine, erythromycin, gentamicin, and kanamycin may be too high to be of benefit in the nasal turbinates, even though the isolates were reported as moderately or fully susceptible. The use of spectinomycin, sulfadimethoxine, and tylosin probably would not be beneficial due to the high MIC values found with these isolates. Oxytetracycline and sulfonamides have been used for some time in the control of AR. 9 However, it would appear that sulfachlorpyridazine or sulfadimethoxine given orally or parenterally would have little effect on P. multocida type D in the turbinates, since an MIC probably would not be achieved. Perhaps a different sulfonamide should be evaluated for the treatment of AR.
The use of oxytetracycline is of particular interest as the MIC,, was 1 µg/ml and MIC 90 was 16 µg/ml, which indicates some of the isolates were susceptible and others were resistant. Because oxytetracycline is frequently used to treat Bordetella bronchiseptica, knowing the MIC of the P. multocida isolate would be beneficial as one microorganism may be controlled but not the other.
The MIC,, and MIC,, provide a measure of resistance in a bacterial population. 8 However, data are needed that relate dose of antimicrobial agent, route of administration, and achievable levels at the site of infection rather than serum levels. These data, in conjunction with an MIC report, will encourage the use of correct antimicrobial agents and the favorable outcome of treatment.
